| Title |
|
|
|
14-3-3 -isoform detection distinguishes sporadic Creutzfeldt-Jakob disease from other dementias
|
|
| Author |
|
|
|
|
|
| Abstract |
|
|
|
| We developed a polyclonal antiserum directed to the gamma-isoform of the human 14-3-3 protein and compared the immunoreactivity with a commercially available antibody (CG31). We analysed 14-3-3 in 253 cerebrospinal fluid samples blinded for the diagnosis by western blot and ELISA, with a commonly used polyclonal antiserum (Sc-731) and the c specific antibodies. Our patient population consisted of 52 patients with definite sporadic Creutzfeldt - Jakob disease (sCJD) and 201 patients with a different final diagnosis. We obtained similar sensitivity, ranging from 96% to 98% with all antibodies. Of all the samples that were false positive with Sc-731, 50% were negative with both gamma-isoform specific antibodies resulting in a significantly higher specificity (85% v 93%, respectively). If only sCJD and patients with dementia differing from sCJD were analysed we found that 64% of false positives were negative which also resulted in significantly increased specificity and positive predictive value. The gamma-isoform specific antibodies strongly improve the specificity of the immunoblot and might improve worldwide acceptance of the use of the 14-3-3 assay in the differential diagnosis of sCJD. | |
|
| Language |
|
|
|
English
|
|
| Source (journal) |
|
|
|
Journal of neurology, neurosurgery and psychiatry. - London |
|
| Publication |
|
|
|
London : 2005
|
|
| ISSN |
|
|
|
0022-3050
|
|
| Volume/pages |
|
|
|
76:1(2005), p. 100-102
|
|
| ISI |
|
|
|
000225777400020
|
|
| Full text (Publisher's DOI) |
|
|
| |
|
| Full text (publisher's version - intranet only) |
|
|
| |
|